Authors/Disclosures
|
Janaiah Kota
(The Research Institute at Nationwide Children)
|
No disclosure on file |
|
Christopher Shilling, MS
(Nationwide Children'S Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
Sarah E. Lewis
(Sarepta Therapeutics)
|
Mrs. Lewis has received personal compensation for serving as an employee of Sarepta Therapeutics . Mrs. Lewis has stock in Sarepta Therapeutics. |
|
Andrew Cole, MD, FAAN
(Massachusetts General Hospital)
|
Dr. Cole has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Cole has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Xiomara Q. Rosales, MD
(Columbia University Medical Center-Neuromuscular Division)
|
No disclosure on file |
|
Laurence M. Viollet, PhD
|
No disclosure on file |
|
Kevin M. Flanigan, MD, FAAN
(Nationwide CHildrens Hospital)
|
Dr. Flanigan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apic Bio. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AavantiBio. Dr. Flanigan has stock in 4D Molecular Therapeutics. The institution of Dr. Flanigan has received research support from Abeona Therapeutics. The institution of Dr. Flanigan has received research support from Sarepta Therapeutics. The institution of Dr. Flanigan has received research support from Astellas Therapeutics. Dr. Flanigan has received intellectual property interests from a discovery or technology relating to health care. |
|
Reed Clark
|
No disclosure on file |
|
Brian K. Kaspar, PhD
|
No disclosure on file |
|
Zarife Sahenk, MD, PhD, FAAN
(The Research Institute at Nationwide Childrens.org)
|
Dr. Sahenk has nothing to disclose. |
|
Jerry R. Mendell, MD, FAAN
(The Research Institute at Nationwide Children's Hospital)
|
Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta. |